• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number H7493926038220
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 04/30/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Age at time of event: 70-80 years old.Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the mid left anterior descending artery.Following rotational atherectomy, pre-dilation was performed and a stent was deployed.The vessel appeared not prepped enough, thus a 2.25 x 38 synergy ii drug-eluting stent was advanced.However, when the device was pulled out, it was noted that the shaft was broken.The procedure was completed with a different device.No patient complications were reported.
 
Additional Manufacturer Narrative
  device evaluated by mfr.: the stent delivery system was returned for analysis without the manifold/hub therefore the catheter serial number could not be identified.A visual examination of the stent found no issues on the stent.There were no signs of damage, stretching or lifting of the stent struts.The stent showed no signs of movement and was set equidistant between the proximal and distal markerbands.The crimped stent od (outer diameter) was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.The tip was visually and microscopically examined and signs of damage were noted on the distal edge of the tip.A visual and tactile examination found a hypotube break at 1200mm proximal to the distal end of the tip.The location of the break from the distal end of the strain relief is 240mm.Multiple hypotube kinks were also noted during device examination.The type of damage noted most likely occurred due to excessive forces that could have been applied on the delivery system.A visual and tactile examination of the outer and mid-shaft section found no issues with the extrusion shaft.The bi-component bond showed no signs of damage or strain.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is operational context as the product meets the design and manufacture specification but due to anatomical/procedural factors encountered during the procedure, performance was limited.(b)(4).
 
Event or Problem Description
It was reported that shaft break occurred.The target lesion was located in the mid left anterior descending artery.Following rotational atherectomy, pre-dilation was performed and a stent was deployed.The vessel appeared not prepped enough, thus a 2.25 x 38 synergy ii drug-eluting stent was advanced.However, when the device was pulled out, it was noted that the shaft was broken.The procedure was completed with a different device.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY II EVEROLIMUS-ELUTING PLATINUM CHROMIUM CORONARY STENT SYSTEM
Common Device Name
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7540365
Report Number2134265-2018-04467
Device Sequence Number1898545
Product Code NIQ
UDI-Device Identifier08714729840381
UDI-Public08714729840381
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
P150003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/30/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date01/31/2019
Device Model NumberH7493926038220
Device Catalogue Number39260-3822
Device Lot Number0021724153
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/04/2018
Initial Date Received by Manufacturer 04/30/2018
Supplement Date Received by Manufacturer05/29/2018
Initial Report FDA Received Date05/24/2018
Supplement Report FDA Received Date06/22/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-